MedPath

The effect of NIMV on premature infants

Not Applicable
Conditions
Respiratory distress syndrom.
Respiratory distress syndrom
Registration Number
IRCT2014021410026N4
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
98
Inclusion Criteria

premature infants, weighing less than 1500 g and RDS symptoms requires treatment.
Exclusion criteria: are major congenital anomalies; respiratory anomalies; orofacial malformations and cyanotic heart diseases.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of NIMV on need for intubation/endotracheal tube ventilation. Timepoint: Within the ?rst 48 h of life. Method of measurement: Clinical evidence of respiratory distress & ABG.;The duration of non-invasive respiratory support. Timepoint: Within the ?rst 48 h of study. Method of measurement: Clinical evidence of respiratory distress $ ?ABG.
Secondary Outcome Measures
NameTimeMethod
eeded to surfactant. Timepoint: During first 48 h of life. Method of measurement: Daily recorded sheets.;Duration of dependency to oxygen. Timepoint: First month of life. Method of measurement: Daily recorded sheets.;Time to full enteral feeds. Timepoint: During first month of life. Method of measurement: Daily recorded sheets.;Hospitalization time. Timepoint: During first month of life. Method of measurement: Daily recorded sheets.;Pneumothorax. Timepoint: During first month of life. Method of measurement: Daily recorded sheets.
© Copyright 2025. All Rights Reserved by MedPath